Valeant Pharmaceuticals International
Date | Investors | Amount | Round |
---|---|---|---|
- | N/A | - | |
N/A | N/A | IPO | |
N/A | $1.5b | Post IPO Debt | |
N/A | $900m | Post IPO Debt | |
N/A | $1.0b | Post IPO Debt | |
N/A | $3.3b | Post IPO Debt | |
N/A | $200m | Post IPO Debt | |
N/A | $1.5b | Post IPO Debt | |
Total Funding | - |
Related Content
Recent News about Valeant Pharmaceuticals International
EditBausch Health Companies Inc. operates as a global leader in the healthcare sector, focusing on pharmaceuticals, medical devices, and over-the-counter consumer health products. Serving a diverse range of clients, including hospitals, healthcare providers, and individual consumers, Bausch Health aims to improve lives through its extensive portfolio of products. The company operates in various markets worldwide, leveraging its broad distribution network to reach over 150 million people daily. Bausch Health's business model revolves around the development, manufacturing, and marketing of its healthcare products, generating revenue through direct sales and partnerships with healthcare institutions. The company continues to gain momentum, positioning itself as a turnaround opportunity with significant growth potential.
Keywords: pharmaceuticals, medical devices, consumer health, global leader, healthcare products, hospitals, healthcare providers, individual consumers, distribution network, turnaround opportunity.